R & D to develop Execabase to combat S. aureus

Award Notice Posted

Solicitation number
21C00021
Agency
Awarded
to Contrafect Corporation
Set-aside
No set-aside

Opportunity facts

Contract number
75A50121C00021 Federal contract award
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Place of performance
Yonkers NY 10701 USA

Notice details come from SAM.gov. Updated .

About this opportunity

The Award Notice is for a contract awarded to CONTRAFECT CORPORATION by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The contract, valued at $8,680,722.80, is for research and development efforts to develop Execabase to combat Staphylococcus aureus. The negotiated award was not fixed price and not competitively bid based on a previous Broad Agency Announcement.

Notice text

Not fixed price and not competetive.  Negotiated award based on Broad Agency Announcement

Awarded contract 75A50121C00021 to CONTRAFECT CORPORATION for 86807228.00 on 3031-03-10.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity